EP2975942
TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.3.2014EP published:
8.8.2018EP application number:
14770870.5
EPO information:
European Patent Register
Max expiry date:
19.3.2034
Title:
TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES
Timeline
Today
20.3.2014EP application
8.8.2018EP Publication
Owner
Name:
Sangamo Therapeutics, Inc.Address:
501 Canal Blvd. Suite A100, 94804, Richmond, CA, US
Name:
Ospedale San Raffaele S.r.l.Address:
Via Olgettina 60, 20132, Milano, IT
Inventor
Name:
GREGORY, Philip D.Address:
Richmond, California, US
Name:
HOLMES, Michael C.Address:
Richmond, California, US
Name:
PASCHON, DavidAddress:
Richmond, California, US
Name:
ZHANG, LeiAddress:
Richmond, California, US
Name:
BONINI, Maria ChiaraAddress:
Milan, IT
Name:
GENOVESE, PietroAddress:
Milan, IT
Name:
MAGNANI, ZulmaAddress:
Milan, IT
Name:
MASTAGLIO, SaraAddress:
Milan, IT
Name:
NALDINI, LuigiAddress:
Milan, IT
Priority
Number:
201361804076 PDate:
21.3.2013Country:
US
Classification
Categories:
A01N 63/00, C12N 9/16, C12N 15/00, C07H 21/04